Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome λ-display library

FEMS Microbiology Letters

Volumn 262, Issue 1, 2006, Pages 14-21

  Beghetto, Elisa ^a   Gargano, Nicola ^a   Ricci, Susanna ^b   Garufi, Gabriella ^c   Peppoloni, Samuele ^d   Montagnani, Francesca ^b   Oggioni, Marco ^b   Pozzi, Gianni ^b   Felici, Franco ^a,c  

^a Kenton Labs   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

phage display; Expression library; Pneumococcal antigen; Streptococcus pneumoniae

Indexed keywords

BACTERIAL PROTEIN; BINDING PROTEIN; EPITOPE; GENE PRODUCT; METALLOPROTEINASE; PROTEIN CBPD; PROTEIN PHTD; PROTEIN PHTE; PROTEIN PSPA; PROTEIN SPR0075; PROTEIN ZMPB; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; BACTERIAL GENOME; BACTERIOPHAGE LAMBDA; IMMUNE RESPONSE; MENINGITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OTITIS MEDIA; PHAGE DISPLAY; PNEUMONIA; PRIORITY JOURNAL; SEPSIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ADULT; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, B-LYMPHOCYTE; GENOME, BACTERIAL; HUMANS; HYDROLASES; MALE; METALLOENDOPEPTIDASES; MICE; MICE, INBRED CBA; PEPTIDE LIBRARY; RECOMBINANT FUSION PROTEINS; SERUM; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PNEUMONIAE;

EID: 33747074334     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2006.00360.x     Document Type: Article

References (34)

1. Adamou JE, Heinrichs JH, Erwin AL et al. (2001) Identification and characterization of a novel family of pneumococcal proteins that are protective in sepsis. Infect Immun 69: 949-958.
2. Avery OT, MacLeod CM & McCarty M (1944) Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Induction of transformation by a deoxyribonucleic acid fraction isolated from Pneumococcus type III. J Exp Med 79: 137-158.
3. Beghetto E, Pucci A, Minenkova O, Spadoni A, Bruno L, Buffolano W, Soldati D, Felici F & Gargano N (2001) Identification of a human immunodominant B-cell epitope within the GRA1 antigen of Toxoplasma gondii by phage display of cDNA libraries. Int J Parasitol 31: 1659-1668.
4. Beghetto E, Spadoni A, Buffolano W, Del Pezzo MA, Minenkova O, Pavoni E, Pucci A, Cortese R, Felici F & Gargano N (2003) Molecular dissection of the human B-cell response against Toxoplasma gondii infection by lambda display of cDNA libraries. Int J Parasitol 33: 163-173.
5. Beghetto E, Nielsen HV, Del Porto P, Buffolano W, Guglietta S, Felici F, Petersen E & Gargano N (2005) A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts. J Infect Dis 191: 637-645.
6. Black SB, Shinefield HR, Hansen J, Elvin L, Laufer D & Malinoski F (2001) Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 20: 1105-1107.
7. Bogaert D, De Groot R & Hermans PW (2004a) Streptococcus pneumoniae colonization: the key to pneumococcal disease. Lancet Infect Dis 4: 144-154.
8. Bogaert D, Sluijter M, De Groot R & Hermans PW (2004b) Multiplex opsonophagocytosis assay (MOPA): a useful tool for the monitoring of the 7-valent pneumococcal conjugate vaccine. Vaccine 22: 4014-4020.
9. Briles DE, Hollingshead SK, Nabors GS, Paton JC & Brooks-Walter A (2000) The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae. Vaccine 19: S87-S95.
10. Butler JC, Shapiro ED & Carlone GM (1999) Pneumococcal vaccines: history, current status, and future directions. Am J Med 107: 69S-76S.
11. Chiavolini D, Memmi G, Maggi T, Iannelli F, Pozzi G & Oggioni MR (2003) The three extra-cellular zinc metalloproteinases of Streptococcus pneumoniae have a different impact on virulence in mice. BMC Microbiol 3: 14.
12. Dagan R, Isaachson M, Lang R, Karpuch J, Block C & Amir J (1994) Epidemiology of pediatric meningitis caused by a Haemophilus influenzae type b, Streptococcus pneumoniae and Nesseria meningitidis in Israel. J Infect Dis 169: 912-916.
13. Di Cristina M, Del Porto P, Buffolano W, Beghetto E, Spadoni A, Guglietta S, Piccolella E, Felici F & Gargano N (2004) The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infection. Microbes Infect 6: 164-171.
14. Ejstrud P, Hansen JB & Andreasen DA (1997) Prophylaxis against pneumococcal infection after splenoctomy: a challenge for hospitals and primary care. Eur J Surg 163: 733-738.
15. Fedson DS, Anthony J & Scott G (1999) The burden of pneumococcal disease among adults in developed and developing countries: what is known and what is not known. Vaccine 17: S11-S18.
16. Gosink K, Mann ER, Guglielmo C, Tuomanen EI & Masure HR (2000) Role of novel choline binding proteins in virulence of Streptococcus pneumoniae. Infect Immun 68: 5690-5695.
17. Hamel J, Charland N, Pineau I, Ouellet C, Rioux S, Martin D & Brodeur BR (2004) Prevention of pneumococcal disease in mice immunized with conserved surface-accessible proteins. Infect Immun 72: 2659-2670.
18. Hausdorff WP, Feikin DR & Klugman KP (2005) Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 5: 83-93.
19. Horton RM, Cai Z, Ho SN & Pease LN (1990) Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. BioTechniques 8: 528-532.
20. Hoskins J, Alborn WE Jr, Arnold J et al. (2001) Genome of the bacterium Streptococcus pneumoniae strain R6. J Bacteriol 183: 5709-5717.
21. Iannelli F, Pearce BJ & Pozzi G (1999) The type 2 capsule locus of Streptococcus pneumoniae. J Bacteriol 81: 2652-2654.
22. Kausmally L, Johnsborg O, Lunde M, Knutsen E & Havarstein LS (2005) Choline-binding protein D (CbpD) in Streptococcus pneumoniae is essential for competence-induced cell lysis. J Bacteriol 187: 4338-4345.
23. McDaniel LS, Sheffield JS, Swiatlo E, Yother J, Crain MJ & Briles DE (1992) Molecular localization of variable and conserved regions of pspA and identification of additional pspA homologous sequences in Streptococcus pneumoniae. Microb Pathogen 13: 261-269.
24. Minenkova O, Pucci A, Pavoni E et al. (2003) Identification of tumor-associated antigens by screening phage-displayed human cDNA libraries with sera from tumor patients. Int J Cancer 106: 534-544.
25. Novak R, Charpentier E, Braun JS, Park E, Murti S, Tuomanen E & Masure R (2000) Extracellular targeting of choline-binding proteins in Streptococcus pneumoniae by a zinc metalloprotease. Mol Microbiol 36: 366-376.
26. Obaro SK (2002) The new pneumococcal vaccine. Clin Microbiol Infect 8: 623-633.
27. Pearce BJ, Iannelli F & Pozzi G (2002) Construction of new unencapsulated (rough) strains of Streptococcus pneumoniae. Res Microbiol 153: 243-247.
28. Rapola S, Jantti V, Haikala R et al. (2000) Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media. J Infect Dis 182: 1146-1152.
29. Sambrook J & Russell DW (2001) Molecular Cloning: A Laboratory Manual, 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
30. Santini C, Brennan D, Mennuni C, Hoess RH, Nicosia A & Cortese R (1998) Efficient display of an HCV cDNA expression library as C-terminal fusion to the capsid protein D of bacteriophage lambda. J Mol Biol 282: 125-131.
31. Schneewind O, Mihaylova-Petkov D & Model P (1993) Cell wall sorting signals in surface proteins of gram-positive bacteria. EMBO J 12: 4803-4811.
32. Shoemaker NB & Guild WR (1974) Destruction of low efficiency markers is a slow process occurring at a heteroduplex stage of transformation. Mol Gen Genet 128: 283-290.
33. Tuomanen EI (2000) Pathogenesis of pneumococcal inflammation: otitis media. Vaccine 19: S38-S40.
34. Virolainen A, Russel H, Crain MJ, Rapola S, Kaythy H & Briles DE (2000) Human antibodies to pneumococcal surface protein A in health and disease. Pediatr Infect Dis J 19: 134-138.